{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T13:41:38Z","timestamp":1770903698734,"version":"3.50.1"},"publisher-location":"Totowa, NJ","reference-count":18,"publisher":"Humana Press","isbn-type":[{"value":"9781617790676","type":"print"},{"value":"9781617790683","type":"electronic"}],"license":[{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011]]},"DOI":"10.1007\/978-1-61779-068-3_17","type":"book-chapter","created":{"date-parts":[[2011,4,5]],"date-time":"2011-04-05T18:56:18Z","timestamp":1302029778000},"page":"259-265","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["A Protocol for the Preparation of Cryoprecipitate and Cryodepleted Plasma"],"prefix":"10.1007","author":[{"given":"Rosemary L.","family":"Sparrow","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David W.","family":"Greening","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard J.","family":"Simpson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,2,23]]},"reference":[{"key":"17_CR1_17","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1038\/203312a0","volume":"203","author":"JG Pool","year":"1964","unstructured":"Pool, J.G., E.J. Gershgold, and A.R. Pappenhagen (1964), High-Potency Antihaemophilic Factor Concentrate Prepared from Cryoglobulin Precipitate. Nature. 203, 312.","journal-title":"Nature."},{"key":"17_CR2_17","first-page":"70","volume":"84","author":"JG Pool","year":"1965","unstructured":"Pool, J.G. (1965), Preparation and testing of antihemophilic globulin (Factor 8) sources for transfusion therapy in hemophilia. Description of a new sterile concentrate process for blood banks. Scand J Clin Lab Invest. 17, p. Suppl 84, 70\u20137.","journal-title":"Suppl"},{"issue":"3","key":"17_CR3_17","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.tmrv.2009.03.001","volume":"23","author":"JL Callum","year":"2009","unstructured":"Callum, J.L., K. Karkouti, and Y. Lin (2009), Cryoprecipitate: the current state of knowledge. Transfus Med Rev. 23(3), 177\u201388.","journal-title":"Transfus Med Rev."},{"issue":"1","key":"17_CR4_17","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.beha.2005.01.026","volume":"19","author":"WN Erber","year":"2006","unstructured":"Erber, W.N. and D.J. Perry (2006), Plasma and plasma products in the treatment of massive haemorrhage. Best Pract Res Clin Haematol. 19(1), 97\u2013112.","journal-title":"Best Pract Res Clin Haematol."},{"issue":"8079","key":"17_CR5_17","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/S0140-6736(78)91324-7","volume":"2","author":"EC Mason","year":"1978","unstructured":"Mason, E.C. (1978), Thaw-siphon technique for production of cryoprecipitate concentrate of factor VIII. Lancet. 2(8079), 15\u20137.","journal-title":"Lancet."},{"issue":"1","key":"17_CR6_17","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1046\/j.1537-2995.1979.19179160274.x","volume":"19","author":"GA Rock","year":"1979","unstructured":"Rock, G.A. and P. Tittley (1979), The effects of temperature variations on cryoprecipitate. Transfusion. 19(1), 86\u20139.","journal-title":"Transfusion."},{"issue":"5","key":"17_CR7_17","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1111\/j.1423-0410.1979.tb04437.x","volume":"36","author":"GA Rock","year":"1979","unstructured":"Rock, G.A., W.H. Cruickshank, E.S. Tackaberry, et al. (1979), Improved yields of factor VIII from heparinized plasma. Vox Sang. 36(5), 294\u2013300.","journal-title":"Vox Sang."},{"key":"17_CR8_17","first-page":"60a","volume":"98","author":"E Shanbrom","year":"2001","unstructured":"Shanbrom, E. and W.J. Owens (2001), A novel method to enhance the formation of cryoprecipitate from fresh plasma. Blood. 98, 60a.","journal-title":"Blood."},{"issue":"4","key":"17_CR9_17","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1111\/j.1365-2257.2006.00785.x","volume":"28","author":"H Yousef","year":"2006","unstructured":"Yousef, H., D. Neurath, M. Freedman, et al. (2006), Cryoprecipitate production: the use of additives to enhance the yield. Clin Lab Haematol. 28(4), 237\u201340.","journal-title":"Clin Lab Haematol."},{"key":"17_CR10_17","unstructured":"(2009), American Association of Blood Banks. Technical Manual. 23rd ed, ed. M. Bethesda."},{"issue":"4","key":"17_CR11_17","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/j.1423-0410.1980.tb02358.x","volume":"38","author":"R.T. Wensley","year":"1980","unstructured":"Wensley, R.T. and T.J. Snape (1980), Preparation of improved cryoprecipitated factor VIII concentrate. A controlled study of three variables affecting the yield. Vox Sang. 38(4), 222\u20138.","journal-title":"Vox Sang."},{"issue":"3","key":"17_CR12_17","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1159\/000119543","volume":"26","author":"E Meilin","year":"2008","unstructured":"Meilin, E., S. Sela, and B. Kristal (2008), Heparin cryoprecipitation reduces plasma levels of non-traditional risk factors for atherosclerosis in vitro. Blood Purif. 26(3), 238\u201348.","journal-title":"Blood Purif."},{"key":"17_CR13_17","unstructured":"(2004), Menitove J. 5.7.5.14 Standards of Blood Banks and Transfusion Services. American Association of Blood Banks..ed 23rd, ed. M.D. Bethesda. U.S.A. 30."},{"issue":"2","key":"17_CR14_17","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.tmrv.2008.12.004","volume":"23","author":"C Prowse","year":"2009","unstructured":"Prowse, C. (2009), Properties of pathogen-inactivated plasma components. Transfus Med Rev. 23(2), 124\u201333.","journal-title":"Transfus Med Rev."},{"issue":"4","key":"17_CR15_17","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1111\/j.1537-2995.2008.02039.x","volume":"49","author":"R Cardigan","year":"2009","unstructured":"Cardigan, R., K. Philpot, P. Cookson, et al. (2009), Thrombin generation and clot formation in methylene blue-treated plasma and cryoprecipitate. Transfusion. 49(4), 696\u2013703.","journal-title":"Transfusion."},{"issue":"10","key":"17_CR16_17","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.1111\/j.1537-2995.2009.02272.x","volume":"49","author":"VS Hornsey","year":"2009","unstructured":"Hornsey, V.S., O. Drummond, A. Morrison, et al. (2009), Pathogen reduction of fresh plasma using riboflavin and ultraviolet light: effects on plasma coagulation proteins. Transfusion. 49(10), 2167\u201372.","journal-title":"Transfusion."},{"issue":"1","key":"17_CR17_17","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1182\/blood.V68.1.307.307","volume":"68","author":"JN George","year":"1986","unstructured":"George, J.N., E.B. Pickett, and R. Heinz (1986), Platelet membrane microparticles in blood bank fresh frozen plasma and cryoprecipitate. Blood. 68(1), 307\u20139.","journal-title":"Blood."},{"issue":"2","key":"17_CR18_17","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1111\/j.1423-0410.1979.tb04402.x","volume":"36","author":"BA McVerry","year":"1979","unstructured":"McVerry, B.A. and S.J. Machin (1979), Incidence of allo-immunization and allergic reactions to cryoprecipitate in haemophilia. Vox Sang. 36(2), 77\u201380.","journal-title":"Vox Sang."}],"container-title":["Methods in Molecular Biology","Serum\/Plasma Proteomics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-61779-068-3_17","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,17]],"date-time":"2020-06-17T19:43:30Z","timestamp":1592423010000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-61779-068-3_17"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011]]},"ISBN":["9781617790676","9781617790683"],"references-count":18,"URL":"https:\/\/doi.org\/10.1007\/978-1-61779-068-3_17","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011]]},"assertion":[{"value":"23 February 2011","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}